167 related articles for article (PubMed ID: 22690789)
21. Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide-induced toxicity.
Thapa A; Vernon BC; De la Peña K; Soliz G; Moreno HA; López GP; Chi EY
Langmuir; 2013 Sep; 29(37):11713-23. PubMed ID: 24004419
[TBL] [Abstract][Full Text] [Related]
22. Heme prevents amyloid beta peptide aggregation through hydrophobic interaction based on molecular dynamics simulation.
Zhao LN; Mu Y; Chew LY
Phys Chem Chem Phys; 2013 Sep; 15(33):14098-106. PubMed ID: 23868536
[TBL] [Abstract][Full Text] [Related]
23. Mapping conformational ensembles of aβ oligomers in molecular dynamics simulations.
Kim S; Takeda T; Klimov DK
Biophys J; 2010 Sep; 99(6):1949-58. PubMed ID: 20858441
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
[TBL] [Abstract][Full Text] [Related]
25. Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix.
Sparks S; Liu G; Robbins KJ; Lazo ND
Biochem Biophys Res Commun; 2012 Jun; 422(4):551-5. PubMed ID: 22579683
[TBL] [Abstract][Full Text] [Related]
26. In silico investigation and targeting of amyloid β oligomers of different size.
Autiero I; Saviano M; Langella E
Mol Biosyst; 2013 Aug; 9(8):2118-24. PubMed ID: 23708585
[TBL] [Abstract][Full Text] [Related]
27. Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease.
Orjuela A; Lakey-Beitia J; Mojica-Flores R; Hegde ML; Lans I; Alí-Torres J; Rao KS
J Alzheimers Dis; 2021; 82(s1):S321-S333. PubMed ID: 33337368
[TBL] [Abstract][Full Text] [Related]
28. Keto form of curcumin derivatives strongly binds to Aβ oligomers but not fibrils.
Yanagisawa D; Kato T; Taguchi H; Shirai N; Hirao K; Sogabe T; Tomiyama T; Gamo K; Hirahara Y; Kitada M; Tooyama I
Biomaterials; 2021 Mar; 270():120686. PubMed ID: 33540171
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study.
Doytchinova I; Atanasova M; Salamanova E; Ivanov S; Dimitrov I
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942739
[TBL] [Abstract][Full Text] [Related]
30. Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils.
Martin TD; Malagodi AJ; Chi EY; Evans DG
J Phys Chem B; 2019 Jan; 123(3):551-560. PubMed ID: 30571122
[TBL] [Abstract][Full Text] [Related]
31. Ion mobility spectrometry reveals the mechanism of amyloid formation of Aβ(25-35) and its modulation by inhibitors at the molecular level: epigallocatechin gallate and scyllo-inositol.
Bleiholder C; Do TD; Wu C; Economou NJ; Bernstein SS; Buratto SK; Shea JE; Bowers MT
J Am Chem Soc; 2013 Nov; 135(45):16926-37. PubMed ID: 24131107
[TBL] [Abstract][Full Text] [Related]
32. Aggregation of Aβ(17-36) in the Presence of Naturally Occurring Phenolic Inhibitors Using Coarse-Grained Simulations.
Wang Y; Latshaw DC; Hall CK
J Mol Biol; 2017 Dec; 429(24):3893-3908. PubMed ID: 29031698
[TBL] [Abstract][Full Text] [Related]
33. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
34. Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2018 Feb; 36(2):407-422. PubMed ID: 28054501
[TBL] [Abstract][Full Text] [Related]
35. Carbon nanotube inhibits the formation of β-sheet-rich oligomers of the Alzheimer's amyloid-β(16-22) peptide.
Li H; Luo Y; Derreumaux P; Wei G
Biophys J; 2011 Nov; 101(9):2267-76. PubMed ID: 22067167
[TBL] [Abstract][Full Text] [Related]
36. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
Lam AR; Teplow DB; Stanley HE; Urbanc B
J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
[TBL] [Abstract][Full Text] [Related]
37. Insights into the mechanism of interaction between trehalose-conjugated beta-sheet breaker peptides and Aβ(1-42) fibrils by molecular dynamics simulations.
Autiero I; Langella E; Saviano M
Mol Biosyst; 2013 Nov; 9(11):2835-41. PubMed ID: 24056531
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-β: the seeds of darkness.
Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
[TBL] [Abstract][Full Text] [Related]
39. Alzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form.
Geng J; Zhao C; Ren J; Qu X
Chem Commun (Camb); 2010 Oct; 46(38):7187-9. PubMed ID: 20820525
[TBL] [Abstract][Full Text] [Related]
40. Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes.
Tofoleanu F; Buchete NV
J Mol Biol; 2012 Aug; 421(4-5):572-86. PubMed ID: 22281438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
